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(SERCA2a) decrease in diabetes, leading to diastolic and systolic
dysfunction of myocardium. It was recently reported that SUMOyla-
tion could elevate the activity and stability of SERCA2a. We assume
that diabetes might affect the intensity of SUMOylation of SERCA2a
after MI.
METHODS Diet-induced type 2 diabetic rats and controls were divided
into suture ligation induced MI groups or sham groups. Primary car-
diomyocytes were cultured in different concentrations of glucose and
insulin, and underwent oxygen deprivation(OD) for 6 or 12 hours.
Echocardiograph and left ventricular pressure were measured to
determine cardiac function. The intensity of SUMOylation of SER-
CA2a, expressions of SERCA2a, SUMO1 and enzymes of SUMOylation
were evaluated.
RESULTS Diabetes exacerbated diastolic and systolic dysfunction of
myocardium after infarction. SUMOylation intensity of SERCA2a
was enhanced in 1-week-post-MI non-diabetic rats and 6-hour-OD
cardiomyocytes but not in 4-week-post-MI rats and 12-hour-OD
cardiomyocytes. The expression of enzyme 2 of SUMOylation,
namely Ubc9, was in accordance with the SUMOylation intensity,
while SUMO1 and enzyme 1 were not changed. This compensatory
enhancement was almost completely blunted in 1 or 4 weeks
post-MI diabetic rats. Interestingly, glucose alone increased Ubc9
expression and the SUMOylation intensity of SERCA2a of car-
diomyocytes in vitro in a concentration-dependent manner; how-
ever, with addition of insulin, glucose decreased Ubc9 and
SUMOylation intensity in a concentration-dependent manner on the
contrary, while SUMO1 and enzyme 1 were also not changed.
Additionally, overexpression of Ubc9 with lentivirus neutralized the
decreasing of SUMOylation intensity caused by glucose and insulin
in vitro.
CONCLUSIONS SUMOylation intensity of SERCA2a was compensa-
tory enhanced in post-MI non-diabetic rats, but not in diabetic rats.
SUMOylation intensity of SERCA2a decreased in cardiomyocytes
with addition of high glucose and insulin in vitro, which could be
neutralized by overexpression of Ubc9. These observations provide
evidence that Ubc9 and SUMOylation of SERCA2a is involved
in diabetes-mediated exacerbation of left ventricular dysfunction
after MI.
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DCPIB Attenuates Myocardial Ischemia/Reperfusion Injury Through
Inhibiting Autophagy in Rat Model
Yuesheng Xia, Lin Wang, Rong Xu, Yuan Xiao, Xiaoming Wang
Department of Geriatrics, Xijing Hospital, Fourth Military Medical
University
OBJECTIVES Autophagy plays a contradictory role in myocardial
ischemia/reperfusion (I/R) process, which acts as both beneﬁcial
cardioprotective during ischemia stress and myocardial injury
in response to subsequent reperfusion. DCPIB (4-[(2-Butyl-6,7-
dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy] buta-
noic acid), a selective inhibitor of volume-sensitive outwardly
rectifying (VSOR) chlorine channel, has been determined to pro-
tect cardiomyocytes from reperfusion damage. However, the un-
derlying mechanism remains unclear. The present study explored
the possible mechanism of DCPIB in alleviating myocardial I/R
injury.
METHODS Sprague-Dawley rats were randomly divided into sham
operation group, I/R group, I/R+Rapamycin (RAPA) group, I/R+DCPIB
group, I/R+3-methyladenine (3MA, a autophagic inhibitor) group and
I/R+RAPA+DCPIB group, with 6 rats in each group. Rats were per-
formed to ischemia 30 minutes and subsequent reperfusion 24 hours,
DCPIB (10mg/kg), RAPA(4mg/kg) and 3MA (1mg/kg) were adminis-
tered as intraperitoneal injection 10 min before the onset of reperfu-
sion, respectively. Serum myocardial enzymes were measured and
light microscopic study was performed, the myocardial LC3 was
detected by immunohistochemistry, nuclear factor-kB (NF-kB) and
tumor necrosis factor a (TNF-a) were detected by enzyme-linked
immunosorbent assay (ELISA).
RESULTS The expressions of myocardial LC3, TNFa and NF-kB
were signiﬁcantly increased (P<0.05), and cardiac function was
declined in I/R group compared with that in sham operation
group (P<0.05), myocardial LC3 were furthermore increased in
RAPA group, whereas these could be reversed through 3MA, a
autophagic inhibitor. Of note, DCPIB administration caused sig-
niﬁcant reduction of myocardial LC3, TNF-a and NF-kB (P<0.05),and signiﬁcantly improved the cardiac functional recovery and
reduced myocardial enzymes activity compared with that in I/R
group and I/R+RAPA+DCPIB group (P<0.05). Speciﬁc details for
hemodynamics, compared to sham-operated group, left ventricular
systolic pressure (LVSP), maximal rate of increase of ventricular
pressure (+dp/dtmax) and maximal rate of decrease of ventricular
pressure (-dp/dtmax) decreased while left ventricular end diastolic
pressure (LVEDP) signiﬁcantly increased markedly in I/R group
and I/R+RAPA group (P<0.05), however, DCPIB indeed reversed
the disorder.
CONCLUSIONS Our results demonstrated that DCPIB attenuated
excessive autophagy to protect rat heart from I/R injury.GW26-e3941
Urokinase Receptor Accelerates Ox-LDL Uptake and Foam Cell Formation
by Upregulating CD36 Expression on Macrophages
Yan Zhang, Wei Chen, Quan Fang
Peking Union Medical College Hospital
OBJECTIVES To investigate the role of uPAR in ox-LDL uptake and
the interaction of uPAR and CD36 in ox-LDL internalization by
macrophages.
METHODS THP-1 cells transfected with uPAR complementary DNA
(uPAR overexpression THP-1, UOT) or with uPAR shRNA (uPAR low-
expression THP-1, ULT) were established. Laser Scanning Confocal
Microscope and dil-ox-LDL were used to evaluate ox-LDL uptake
capacities. Oil red O staining was performed to measure lipid accu-
mulation and foam cell formation. Cytokine expression levels of
cytokines were quantitated by Real-Time-PCR.
RESULTS Ox-LDL-induced uPAR expression was independent of its
baseline expression level in macrophages. UOT cells showed a strong
correlation of uPAR expression with ox-LDL uptake. Much earlier dil-
ox-LDL internalization and signiﬁcantly more lipid droplets were
found in UOT cells. Stable expression of a shRNA targeting uPAR gene
strongly inhibits lipid uptake by macrophages. UOT cells exhibited
signiﬁcantly higher transcriptional levels of CD36 mRNA upon stim-
ulation of ox-LDL.
CONCLUSIONS uPAR accelerates ox-LDL uptake and foam cell
formation in macrophages, which may be mediated by CD36 up-
regulation. The interaction between uPAR and CD36 may be a
potential new therapeutic target.
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Activation of D4 Dopamine Receptor Decreases AT1 Angiotensin II
Receptor Expression in Rat Renal Proximal Tubule Cells
Chen Ken,1,2 Zeng Chunyu1,2
1Department of Cardiology, Hospital of Cardiology in Daping Hospital,
The Third Military Medical University; 2Chongqing Institute of
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OBJECTIVES The dopaminergic and renin angiotensin systems
interact to regulate blood pressure. Disruption of the D4 dopamine
receptor gene in mice produces hypertension that is associated with
increased renal AT1 receptor expression. We hypothesize that D4 re-
ceptor can inhibit AT1 receptor expression and function in renal
proximal tubules (RPTs) cells from Wistar-Kyoto (WKY) rats, the
regulation of D4 receptor on AT1 receptor is aberrant in RPT cells from
spontaneously hypertensive rats (SHRs).
METHODS The AT1 receptor protein expression is detected by
immunoblotting. Na+-K+-ATPase activity was determined as the rate
of inorganic phosphate released in the presence or absence of
ouabain.
RESULTS The D4 receptor agonist, PD168077, decreased AT1 receptor
protein expression in a time (0-30hrs)- and concentration (10-9-10-5M)-
dependent manner in WKY RPT cells. In contrast, in SHR cells,
PD168077 (10-6M) increased AT1 receptor protein expression. The
inhibitory effect of D4 receptor on AT1 receptor expression in WKY
RPT cells was blocked by a calcium channel blocker, nicardipine
(10-6M) or calcium free medium, indicating that calcium channel was
involved as a signaling molecule in the D4 receptor-mediated
signaling pathway. Angiotensin II (10-11M) increased Na+-K+ ATPase
activity in WKY cells. Pretreatment with PD168077 (10-6M/24hrs)
decreased the stimulatory effects of angiotensin II on Na+-K+ ATPase
activity in WKY cells. However, in SHR cells, the inhibitory effect of D4
receptor on angiotensin II-mediated effect on Na+-K+ ATPase activity
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stimulatory effect of AT1 receptor on Na+-K+ ATPase activity in SHR
cells.
CONCLUSIONS We suggest that a differential interaction between D4
and AT1 receptors may play a role in the differential regulation of
sodium excretion and blood pressure in hypertension.
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Cellular Electrophysiological Mechanisms and Drug Intervention Study of
the CACNA1C Gene Mutation Related to Early Repolarization
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Afﬁliated Hospital of Nanchang University
OBJECTIVES To investigate the electrophysiological mechanisms of
mutated cardiac L-type calcium channel (LTCC) caused by a CACNA1C
gene mutation in ER from cellular level, and screening of effective
drug treatment.
METHODS Patients with early repolarization syndrome (ERS) were
recruited according to the 2013 HRS/EHRA/APHRS diagnostic expert
consensus statement. Mutation analysis was detected by direct
sequencing. HEK293 cells were co-transfected with wild type or
mutant human CACNA1C, and its auxiliary unit contained CACNB2b
and CACNA2D1 for the cellular electrophysiological and drug inter-
vention study of LTCC.
RESULTS A missense mutation in CACNA1C gene (c.5747A > G,
p.Q1916R) was identiﬁed in a 34-year-old male patient. The mutant L-
type calcium current (ICa-L) in HEK293 cells declined when compared
to the wild calcium channel, (P＜0.05, P＜0.01), there is no difference
of the voltage dependent SSA between the 2 groups. The testosterone
(10 mM) signiﬁcantly reduces the current density (P ＜0.05). The
therapeutic drug for ERS of isoproterenol (10 mM) increases the wild
calcium current density, while the increased mutant calcium current
density without statistical signiﬁcance. The quinidine (5 mM) has no
any effect on the calcium current density and voltage dependent SSA
in the both groups.
CONCLUSIONS In conclusion, a novel CACNA1C mutation might be
associated with the ERS. The CACNA1C-Q1916R is a loss-of-function
mutation with decreased calcium current. The testosterone exacer-
bates the decreased CACNA1C-Q1916R mutant calcium current den-
sity, which suggests that the male gender is an important risk factor
ERS. There might be no therapeutic effect of isoproterenol in the
CACNA1C-Q1916R mutant carrier related to the early repolarization we
studied here.
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Up-Regulation of Neuronal Nitric Oxide Synthase Modulates Myoﬁlament
Ca2+ Sensitivity and Controls Left Ventricular Myocyte Contractility in
Hypertensive Rats
Lan Cui, Chunzi Jin
Yan Bian University Hospital
OBJECTIVES Hypertension is one of the major risk factors for
developing cardiac hypertrophy and heart failure. Although cellular
signaling pathways, intracellular Ca2+ handling and myoﬁlament
Ca2+ sensitivity are known to be altered in hypertensive myocar-
dium, mechanisms mediating left ventricular (LV) contractile func-
tion remain to be deﬁned. It is known that neuronal nitric oxide
synthase (nNOS) is up-regulated in hypertensive myocardium,
however, its role in myocyte Ca2+ handling and myoﬁlament Ca2+
sensitivity and their interplays in regulating contractile function is
not clear. Therefore, we aim to test the functional regulation by
nNOS of LV myocyte contraction in angiotensin II (Ang II)-induced
hypertensive rats.
METHODS Sprague-Dawley rats (8 weeks old, male) were subjected to
Ang II infusion subcutaneously using osmotic minipump for 4 weeks
(125ng/min/kg). These animals were paired with sham-operated
groups. LV myocytes were isolated using a standard enzymatic
dispersion technique. Contraction and relaxation were measured in
LV myocytes (ﬁeld-stimulation at 2 Hz, 361oC) by using a video-
sarcomere detection system (IonOptix Corp).RESULTS Systemic blood pressure was elevated in Ang II-treated
rats (osmotic minipump, 4 weeks) compared to that in shams.
Functional analysis showed that LV myocyte sarcomere shortening
was unchanged and relaxation was faster in Ang II-rats compared to
those from shams. L-type Ca2+ channel activity (ICa) was not
different between two groups, however, peak [Ca2+]i was increased
(Fura 2, F360/F380) and decay of [Ca2+]i (tau) was faster in Ang II-
rats. These changes were accompanied by reduced myoﬁlament
Ca2+ sensitivity (EC50). Immunoblotting results revealed that nNOS
protein expression was signiﬁcantly increased (optical density of
nNOS/GAPDH) in LV myocyte homogenates from Ang II-rats. Inhi-
bition of nNOS with speciﬁc inhibitors, S-methyl-L-thiocitrulline
(SMTC, 100 nM) or N5-(1-Imino-3-butenyl)-L-ornithine (L-VNIO,
100 uM) restored myoﬁlament Ca2+ sensitivity and reduced [Ca2+]i
in Ang II-rats. As a result, LV myocyte contraction was maintained
unaltered. Interestingly, ICa was increased by nNOS inhibition
(similar to that in sham) but tau of [Ca2+]i was not affected, despite
that relaxation was signiﬁcantly prolonged by SMTC or L-VNIO in
Ang II-rats. A speciﬁc inhibitor of protein kinase G (KT 5823, 1 uM)
mimicked the effect of nNOS and increased myoﬁlament Ca2+
sensitivity, [Ca2+]i and LV myocyte contraction.
CONCLUSIONS These results suggest that reduced myoﬁlament
Ca2+ sensitivity by nNOS plays predominant role in controlling
intracellular Ca2+ handling and LV myocyte contractility in hyper-
tension.GW26-e4492
Inhibition of VDAC1 Prevents Ca2+-Mediated Oxidative Stress and
Apoptosis Induced by 5-Aminolevulinic Acid Mediated Sonodynamic
Therapy in THP-1 Macrophages
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OBJECTIVES Ultrasound combined with endogenous protoporphy-
rin IX derived from 5- aminolevulinic acid (ALA-SDT) is known to
induce apoptosis in multiple cancer cells and macrophages. Persis-
tent retention of macrophages in the plaque has been implicated
in the pathophysiology and progression of atherosclerosis. Here
we investigated the effects of inhibition of voltage-dependent
anion channel 1 (VDAC1) on ALA-SDT-induced THP-1 macrophages
apoptosis.
METHODS Cells were pre-treated with VDAC1 inhibitor 4, 4’ -diiso-
thiocyanostilbene-2, 2’ -disulfonic acid (DIDS) disodium salt for 1 h
or downregulated VDAC1 expression by small interfering RNA and
exposed to ultrasound. Cell viability was assessed by MTT assay,
and cell apoptosis along with necrosis was evaluated by Hoechst
33342/ propidium iodide staining and ﬂow cytometry. Levels of cy-
tochrome c release was assessed by confocal microscope and West-
ern blot. The levels of full length caspases, caspase activation, and
VDAC isoforms were analyzed by Western blot. Intracellular reactive
oxygen species generation, mitochondrial membrane permeability,
and intracellular Ca2+ ([Ca2+]i) levels were measured with ﬂuorescent
probes.
RESULTS The pharmacological inhibition of VDAC1 by DIDS notably
prevented ALA-SDT-induced cell apoptosis in THP-1 macrophages.
DIDS signiﬁcantly inhibited intracellular ROS generation and
apoptotic biochemical changes such as inner mitochondrial mem-
brane permeabilization, loss of mitochondrial membrane potential,
cytochrome c release and activation of caspase-3 and caspase-9.
Moreover, ALA-SDT elevated the [Ca2+]i levels and it was also
notably reduced by DIDS. Furthermore, both of intracellular ROS
generation and cell apoptosis were predominately inhibited by Ca2+
chelating reagent BAPTA-AM. Intriguingly, ALA-treatment markedly
augmented VDAC1 protein levels exclusively, and the down-
regulation of VDAC1 expression by speciﬁc siRNA also signiﬁcantly
abolished cell apoptosis.
CONCLUSIONS VDAC1 plays a crucial role in ALA-SDT-induced THP-1
macrophages apoptosis, and targeting VDAC1 is a potential way
regulating macrophages apoptosis. This ﬁnding may be relevant to
therapeutic strategies against atherosclerosis.
